Mitchell, Jonathan https://orcid.org/0000-0003-3792-4058
Camacho, Niedzica https://orcid.org/0000-0002-0724-760X
Shea, Patrick
Stopsack, Konrad H. https://orcid.org/0000-0002-0722-1311
Joseph, Vijai https://orcid.org/0000-0002-7933-151X
Burren, Oliver S.
Dhindsa, Ryan S. https://orcid.org/0000-0002-8965-0813
Nag, Abhishek
Berchuck, Jacob E. https://orcid.org/0000-0002-7607-2428
O’Neill, Amanda
Abbasi, Ali
Zoghbi, Anthony W.
Alegre-Díaz, Jesus https://orcid.org/0000-0001-9390-3871
Kuri-Morales, Pablo https://orcid.org/0000-0002-0704-9507
Berumen, Jaime https://orcid.org/0000-0001-6707-3317
Tapia-Conyer, Roberto https://orcid.org/0000-0003-3814-2904
Emberson, Jonathan https://orcid.org/0000-0001-7792-9422
Torres, Jason M. https://orcid.org/0000-0002-7537-7035
Collins, Rory
Wang, Quanli
Goldstein, David https://orcid.org/0000-0002-1111-2820
Matakidou, Athena
Haefliger, Carolina https://orcid.org/0000-0002-5095-5716
Anderson-Dring, Lauren
March, Ruth
Jobanputra, Vaidehi
Dougherty, Brian
Carss, Keren https://orcid.org/0000-0003-4939-156X
Petrovski, Slavé https://orcid.org/0000-0002-1527-961X
Kantoff, Philip W.
Offit, Kenneth
Mucci, Lorelei A.
Pomerantz, Mark
Fabre, Margarete A. https://orcid.org/0000-0001-7794-610X
Article History
Received: 10 May 2024
Accepted: 5 February 2025
First Online: 19 February 2025
Competing interests
: J.M., N.C., O.B., R.D., A.N., A.O., A.A., Q.W., L.A.-D., R.M., B.D., K.C., S.P., M.A.F. are current employees and/or stockholders of AstraZeneca. A.W.Z receives grant funding and consulting fees from AstraZeneca. L.A.M. is on the advisory board and holds equity interest in Convergent Therapeutics. A.M. is a former employee of AstraZeneca and current employee of GSK and a stockholder of AstraZeneca and GSK. C.H. was an employee and stockholder of AZ at the time of study and is a current employee of Debiopharm International. P.W.K. is a co-founder and employee of Convergent Therapeutics. The remaining authors declare no competing interests.